While more research is needed, experts consider semaglutide a promising development in addressing alcohol addiction.

How weight loss drugs actually work, and how big-name prescriptions differ from each other. What investors need to know about ...

Dr. Carolyn Brockington, a vascular neurologist, joins TODAY to share the latest advancements in detecting dementia and ...

Kennedy Jr., who was tapped to lead the Department of Health and Human Services for the Trump administration, recently ...

As the potential of GLP-1 agonists for addiction gains traction, big pharma is also starting to take notice, namely the two ...

"It's called GLP-1 receptor," said Dr. Atul Malhotra from the UC San Diego School of Medicine. It’s already FDA-approved to ...

A new study found that fair prices for medications like Wegovy and Zepbound would be hundreds less per month than they are ...

Now, it plans to run studies on how its GLP-1 class of weight loss/diabetes drug can help people deal with addiction. Eli Lilly: The U.S. drugmaker’s weight-loss drug Zepbound became the direct ...

Ricky Mulvey: One of the exciting things about these drugs is they don't just help with weight loss. There's some preliminary examples that folks with addictions may be able to use GLP-1 drugs to ...